Beneficial ownership — 13D / 13G
87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Madryn Asset Management, LP | GBNH Greenbrook TMS Inc. Common Shares | 13D/A | 45% | Oct 12, 2023 | 3y |
| Squarepoint Ops LLC | VNTR Venator Materials PLC | 13D | 17.1% | Oct 12, 2023 | 3y |
| Morsevo Trading, Inc. | KARX Karbon-X Corp. | 13D | 5.8% | Oct 5, 2023 | 3y |
| Arena Capital Advisors, LLC- CA | HCVI Hennessy Capital Investment Corp. VI Class A Common Stock | 13G | 12.1% | Sep 30, 2023 | 3y |
| Jonathan B. Rubini | GMVD G Medical Innovations Holdings Ltd. Ordinary Shares | 13D/A | 23.3% | Sep 29, 2023 | 3y |
| Gerald E. O’Shaughnessy | GPRK GeoPark Ltd | 13D/A | 7.26% | Sep 22, 2023 | 3y |
| Capital World Investors | DBD DIEBOLD NIXDORF, Inc | 13D/A | 33.4% | Aug 11, 2023 | 3y |
| Jacobsen Per A. | BLIN Bridgeline Digital, Inc. | 13G/A | 6.5% | Oct 23, 2023 | 3y |
| Saudi Arabian Mining Company (Ma’aden) | IE Ivanhoe Electric Inc. | 13D/A | 8.7% | Oct 23, 2023 | 3y |
| Bleichroeder LP | INVE INVE Technologies, Inc. | 13D/A | 19.9% | Oct 21, 2023 | 3y |
| EW Healthcare Partners, L.P. | VERO Venus Concept Inc. | 13D/A | 44.2% | Oct 20, 2023 | 3y |
| PERCEPTIVE ADVISORS LLC | SLNO Soleno Therapeutics Inc | 13D/A | 10.1% | Oct 20, 2023 | 3y |
| Mayfield XV, a Cayman Islands Exempted Limited Partnership | GROV Grove Collaborative Holdings, Inc. | 13D/A | 3.6% | Oct 19, 2023 | 3y |
| Scott Stanford | ASTR Astra Space, Inc. Class A Common Stock | 13D/A | 8.6% | Oct 19, 2023 | 3y |
| Saba Capital Management, L.P. | BTX BlackRock Technology & Private Equity Term Trust | 13D/A | 12.65% | Oct 19, 2023 | 3y |
| Saba Capital Management, L.P. | PGZ Principal Real Estate Income Fund | 13D/A | 8.43% | Oct 18, 2023 | 3y |
| Schindel Yair Chaim | ADXS Advaxis, Inc. | 13G/A | 5.21% | Oct 18, 2023 | 3y |
| Avidity Partners Management LP | FUSN Fusion Pharmaceuticals Inc. Common Shares | 13G | 9.7% | Oct 18, 2023 | 3y |
| Corvex Management LP | SWX Southwest Gas Holdings, Inc. | 13D | 5.8% | Oct 16, 2023 | 3y |
| Exor N.V. | CLVT Clarivate PLC | 13D | 6.29% | Oct 12, 2023 | 3y |
| Silver Point Capital L.P. | PRTY Party City Holdco Inc. | 13D | 41% | Oct 12, 2023 | 3y |
| Cormorant Asset Management, LP | ALPN Alpine Immune Sciences, Inc. Common Stock | 13G | 5.79% | Oct 11, 2023 | 3y |
| Kontron AG | BSQR BSQUARE Corporation | 13D | 17.3% | Oct 11, 2023 | 3y |
| SMC Holdings II G.P., LLC | OSA ProSomnus, Inc. Common Stock | 13D | 11.7% | Sep 20, 2023 | 3y |
| Bain Capital Life Sciences Fund II, L.P. | NUVL Nuvalent, Inc. | 13D/A | 4.2% | Oct 19, 2023 | 3y |
| Point72 Asset Management, L.P. | SMTC Semtech Corp | 13G | 7.3% | Oct 19, 2023 | 3y |
| Arturo R. Moreno | CCO Clear Channel Outdoor Holdings, Inc. | 13D/A | 5.6% | Oct 19, 2023 | 3y |
| Bulldog Investors, LLP | PGZ Principal Real Estate Income Fund | 13D/A | 5.92% | Oct 19, 2023 | 3y |
| Chan Wai Ho | MEGL Magic Empire Global Ltd | 13D/A | 34.4% | Oct 19, 2023 | 3y |
| CHEN Sze Hon Johnson | MEGL Magic Empire Global Ltd | 13D/A | 24% | Oct 19, 2023 | 3y |
| Sean McNealy | ABX Abacus Global Management, Inc. | 13D/A | 20% | Oct 13, 2023 | 3y |
| Jay Jackson | ABX Abacus Global Management, Inc. | 13D/A | 20% | Oct 13, 2023 | 3y |
| Matthew Ganovsky | ABX Abacus Global Management, Inc. | 13D/A | 20% | Oct 13, 2023 | 3y |
| Kevin Scott Kirby | ABX Abacus Global Management, Inc. | 13D/A | 20% | Oct 13, 2023 | 3y |
| Novator Capital Sponsor Ltd. | BETR Better Home & Finance Holding Co | 13D/A | 13.6% | Oct 12, 2023 | 3y |
| Deerfield Management Company, L.P. | SILK Silk Road Medical, Inc. Common Stock | 13G | 0% | Oct 11, 2023 | 3y |
| STILWELL JOSEPH | WHLR Wheeler Real Estate Investment Trust, Inc. | 13D/A | 83.7% | Oct 6, 2023 | 3y |
| Ray Prudo, M.D. | AKTX Akari Therapeutics Plc | 13D/A | 21.8% | Oct 6, 2023 | 3y |
| Louis A. DeNaples | FNCB FNCB Bancorp Inc. Common Stock | 13D/A | 10.74% | Sep 27, 2023 | 3y |
| Samsara BioCapital, L.P. | SYRS Syros Pharmaceuticals, Inc. Common Stock | 13D | 7.5% | Jan 15, 2023 | 3y |